1. Introduction {#sec1}
===============

Aging is a multifarious natural process, linked with several biochemical and morphological variations in the biological system [@bib1]. Aging not only challenges the increased vulnerability as well as homeostasis network to the cognition and locomotion but also to physical, mental or social activities. The decrease in the level of polyunsaturated fatty acid like arachidonic acid in membrane fatty acid leads to cognitive deficits in the animal. Oxidative stress is also considered as one of the factors for the root cause of aging [@bib2]. Age-related behavioral changes in motor and cognitive functions are not limited to the presence of neurodegenerative diseases like Alzheimer or Parkinson disease [@bib3]. At the same time, aging could lead to the development of age-related diseases, such as neurodegenerative diseases [@bib4], diabetes [@bib5], and cardiovascular disorders [@bib6], which are life-threatening challenges to the human beings [@bib7].

Medicinal plants have been used since ancient time to cure and prevent various diseases. Several natural compounds such as isoflavones, anthocyanins, and catechins isolated from plant sources act as a potent antioxidant against ROS (Reactive Oxygen Species) [@bib8]. Antioxidants, especially natural antioxidants are recommended for the prevention of aging [@bib9]. Many Chinese medicinal herbs are considered as one of the possible interventions for the development of anti-aging drugs \[[@bib10], [@bib11], [@bib12]\].

D-Galactose induced animal models are widely accepted and commonly used for identifying as well as studying aging, related oxidative damage and memory impairment \[[@bib13], [@bib14]\]. The normal metabolism of D-galactose, which is a reducing sugar controlled by galactose-1-phosphate uridyltransferase and D-galactokinase in animals however excess consumption of D-galactose leads to neurotoxicity because of abnormality in metabolism [@bib15]. The toxicity is because of accumulation of galactitol in the cell, which causes osmotic stress and formation of ROS [@bib16]. Many reports suggest that the formation of advanced glycation end products (AGE) is due to the interaction between D-galactose with the free amino groups of proteins, which further activates the receptor for advanced glycation end products (RAGE). In another word, D-galactose is responsible for oxidative stress and cellular damage \[[@bib17], [@bib18], [@bib19]\].

In this study, we utilized an unexplored traditional medicinal plant *Aporosa octandra* (Buch.-Ham. ex D. Don) that belongs to the family Euphorbiaceae, sub-family Phyllanthaceae which is shrub to tree, up to 15 m high and comprises of 50 species that are distributed throughout India, Nepal, China, Pakistan, Thailand, and Malaysia ([Fig. 1](#fig1){ref-type="fig"}). It is commonly known as "Chantal" in India and "Kalikath" in Nepal. This plant is enlisted as a medicinal plant and is used for centuries in the Ayurvedic system [@bib20].Fig. 1*Aporosa octandra* plant.Fig. 1

The plants of this genus are reported to possess various medicinal properties. Traditionally, a decoction of the *A. octandra* bark (5--15 ml, 3--5 times daily) is used orally for treating inflammation, peptic ulcer, and hypotension. The fruit pulp is used for curing pimples while leaves are used to dye clothes black. Although this plant is used for many years as a traditional medicinal plant yet its phytochemical investigation is not reported to date and also this plant has never been screened for any oxidative stress studies. Therefore, the present study considers the bioassay of the extracts of its bark to explore the effect of behavioral and oxidative damage on D-galactose induced animal model. We have also considered the phytochemical investigation of the extracts.

2. Materials & methods {#sec2}
======================

2.1. General {#sec2.1}
------------

Melting points were measured in a Fischer Johns apparatus and are uncorrected. IR spectra were recorded on a Perkin--Elmer Spectrophotometer using KBr pellets. ^1^H and ^13^C NMR spectra were generated on Bruker 300 Spectrometer in deuterated solvents with TMS as an internal standard. The mass spectra were taken on Jeol Spectrophotometer. Silica gel of 60--120 mesh from Merck used for column chromatography.

2.2. Plant material {#sec2.2}
-------------------

Dried bark of *A. octandra* was collected from Baliguda, Odisha, India and identified by a Scientist from Odisha Forest Development Corporation (OFDC), Bhubaneswar, India. The dried bark was grounded to a fine powder using a blender under aseptic conditions.

2.3. Extraction and isolation {#sec2.3}
-----------------------------

Dried and finely powdered bark (500 g) was extracted with cold CH~2~Cl~2~, CH~2~Cl~2~/MeOH (1:1) and MeOH separately for several hours in succession using mechanical stirrer. The organic solvent was removed from the extracts separately under reduced pressure to obtain dry extracts dichloromethane soluble part (*Aporosa octandra* extract-1, **AOE-1**, 11.2 g), dichloromethane: methanol (50:50) soluble part (*Aporosa octandra* extract-2, **AOE-2**, 15.8 g), and methanol soluble part (*Aporosa octandra* extract-3, **AOE-3**, 7.6 g), respectively. **AOE-2** and **AOE-3** were combined based on TLC similarities and named as **AOE-4**. Extracts **AOE-1** and **AOE-4** were then further fractionated by column chromatography and compounds **AO-1** to **AO-6** were isolated. Based on preliminary α,α-diphenyl-β-picrylhydrazyl (DPPH) free radical scavenging studies with respect to standard ascorbic acid, **AOE-4** was further considered for animal studies.

**Pentyl docosanoate (AO-1).** Low melting solid (12 mg) [@bib21]. IR ν~max~ (KBr): 2916, 2849, 1734, 1472, 1216, 1176, 761 cm^−1^. ^1^H NMR (δ, CDCl~3~, 300 MHz): 4.05 (t, 2H, *J* = 3.8 Hz, -O-CH~2~-), 2.29 (t, 2H, *J* = 4.6 Hz, -CH~2~-C=O-), 1.58 (m, 4H, -CH~2~CH~2~-C=O & -CH~2~CH~2~-O), 1.25 (m, 40H, 20x-CH~2~), 0.87 (t, 6H, *J* = 6.8, 7.0 Hz, 2x-CH~3~). Mass Spectral data, EIMS m/z (%): 410 (100, M^+^), 340 (38), 339 (25), 323 (18), 295 (51), 280 (15), 174 (10), 130 (20), 127 (35), 115 (48), 87 (10), 71 (21), 70 (80).

**Tetradecanoic acid (AO-2).** White solid (15 mg), m.p. 54--56 °C (lit. m.p. 54--55 °C, [@bib22]). IR ν~max~ (KBr): 2916, 2848, 1698, 1454, 1217, 772, 726 cm^−1^. ^1^H NMR(δ, CDCl~3~, 300 MHz): 2.37 (t, 2H, *J* = 7.3 Hz), 1.61 (m, 2H), 1.25 (brs, 20H, 10x-CH~2~-), 0.88 (t, 3H, -CH~3,~ *J* = 6.6 Hz). ^13^C NMR (δ, CDCl~3~, 75.5 MHz): 176.2 (C=O), 33.7, 31.8, 29.5, 29.3, 29.1, 28.7, 24.6, 22.4, 13.9. Mass Spectral data, EIMS m/z (%): 229 (100), 211 (56), 197 (25), 183 (31), 155 (19), 113 (29), 85 (41).

**Stigmast-5-en-3**β**-ol (AO-3).** Colorless needles (40 mg), m.p. 134--135 °C \[lit. 136--137 °C, [@bib23]). IR ν~max~ (KBr): 3550, 3090, 2965, 1639, 1463, 1378, 1058, 1025, 930, 880, 803 cm^−1^. ^1^H NMR (δ, CDCl~3~, 300 MHz): 5.38 (t, 1H, *J* = 6.9 Hz, H-6), 3.42 (m, 1H, H-3α), 2.32--1.34 (m, 3H, -CH~2~-, -CH), 0.99 (s, 3H, 19-CH~3~), 0.89 (d, 3H, *J* = 6.3 Hz, 21-CH~3~), 0.84 (t, 3H, *J* = 7.0 Hz, 29-CH~3~), 0.80 (d, 6H, *J* = 7.0 Hz, 26-CH~3~ & 27-CH~3~), 0.68 (s, 3H, 18-CH~3~). ^13^C NMR (δ, CDCl~3~, 75.5 MHz): 141.2 (C-5), 121.3 (C-6), 71.3 (C-3), 59.9, 56.5, 50.5, 42.4, 40.0, 39.6, 37.5, 36.5, 36.4, 35.8, 32.3, 32.0, 31.6, 29.3, 28.3, 28.0, 24.3, 24.1, 22.5, 22.2, 21.2, 19.4, 18.8, 12.0, 11.3. Mass spectral data, EIMS *m/z* (%): 414 (M^+^, 57), 399 (M^+^-CH~3~, 12), 396 (M^+^-H~2~O, 12), 381 (M^+^-H~2~O-CH~3~, 6), 329 (9), 303 (14), 273 (M^+^-side chain, 19), 255 (12), 232 \[M^+^-side chain-(C-15, C-16 & C-17), (16)\], 213 (12), 173 (8), 164 \[232 -- (C-11, C-12, C-13, C-14 & C-19), (18)\], 145 (20), 133 (19), 107 (35), 95 (37), 81 (45).

**Stigmast-5-en-3-O-**β**-D-galactopyranoside (AO-4).** White crystalline solid (20 mg), m.p. 274-75 °C (lit. m.p. 275-77 °C, [@bib24]). IR ν~max~ (KBr): 3401, 2933, 2870, 1655, 1462, 1369, 1256, 1166, 1072, 1022, 800, 622 cm^−1^. ^1^H NMR (δ, DMSO-d~6~, 300 MHz): 5.33 (t, 1H, *J* = 6.9 Hz, H-6), 4.67 (d, 1H, *J* = 3.6 Hz, -CHOH), 4.60 (d, 1H, *J* = 3.0 Hz, -CHOH), 4.41 (d, 1H, *J* = 3.6 Hz, -CHOH), 4.34 (d, 1H, *J* = 7.5 Hz, H-1′), 3.87 (t, 1H, *J* = 3.4 Hz, -CHOH), 3.77--3.64 (m, 3H, 3x-CHOH), 3.56 (m, 1H, H-3α), 3.37--3.19 (m, 3H, -CH~2~OH, -CHOH), 2.39--1.01 (m, 29H), 0.97 (s, 3H, 19-CH~3~), 0.90 (d, 3H, *J* = 6.3 Hz, 21-CH~3~), 0.85 (t, 3H, *J* = 6.8 Hz, 29-CH~3~), 0.80 (d, 6H, *J* = 6.5 Hz, 26 & 27-CH~3~), 0.68 (s, 3H, 18-CH~3~). ^13^C NMR (δ, DMSO-d~6~, 75.5 MHz): 140.6 (C-5), 121.4 (C-6), 101.1 (C-1′), 77.4 (C-2′, C-3′, C-4′, C-5′), 77.0, 76.6, 73.7, 70.4 (C-3), 61.5 (C-6′), 56.5, 55.7, 49.9, 45.5, 42.1, 40.7, 39.6, 38.6, 37.1, 36.5, 35.7, 33.7, 31.7, 29.5, 29.0, 28.0, 25.8, 24.1, 22.9, 20.8, 19.9, 19.3, 19.1, 18.8, 12.0, 11.8. Mass spectral data, EIMS *m/z* (%): 414 (M^+^-galactose,18), 396 (M^+^-galactose-H~2~O, 16), 381 (M^+^-galactose-H~2~O-CH~3~, 6), 329 (9), 303 (10), 256 (M^+^-galactose-C~10~H~21~, 15), 215 (M^+^-galactose-C~10~H~21~-carbons of C-15, C-16 & C-17, 5), 180 (galactose, 12), 147 (215-carbons of C-11, C-12, C-13, C-14 & C-19, 18), 133 (19), 107 (35), 95 (37), 81 (45), 57 (50), 43 (100).

**(R)-1-(4-hydroxybenzyl)-6-methoxy-1,2,3,4-tetrahydroisoquinolin-7-ol compound with hydrogen sulfide (1:1) hydrate (AO-5).** Colorless crystalline solid (160 mg, obtained from ethanol through slow evaporation technique) having m.p. 258--259 °C. IR ν~max~ (KBr): 3483, 3257, 2925, 1608, 1522, 1447, 1375, 1260, 1206, 1122, 1031, 837, 804, 623 cm^−1^. ^1^H NMR (δ, MeOH-d~4~, 300 MHz): 7.15 (d, 2H, *J* = 8.4 Hz), 6.79 (d, 2H, *J* = 8.4 Hz), 6.74 (s, 1H), 6.64 (s, 1H), 4.58 (t, 1H, *J* = 9.2 Hz), 3.84 (s, 3H, -OCH~3~), 3.46 (m, 2H), 3.33 (m, 2H), 3.01 (m, 2H). ^13^C NMR (δ, MeOH-d~4~, 75.5 MHz): 158.1, 149.2, 146.7, 131.8, 126.9, 124.9, 123.7, 117.0, 114.1, 112.6, 57.9, 56.5, 41.0, 40.5, 26.0. Mass Spectral data, HRMS (+ESI-TOF) *m/z* for C~17~H~19~NO~3~ \[M+1\]^+^calcd. 286.1368, found 286.1375. Specific Rotation: \[α\]^27^ = +2.10 (C: 0.01, Methanol).

**β-D-Fructofuranosyl-α-D-glucopyranoside (AO-6).** White crystaline solid (140 mg), m.p. 187--189 °C (lit. m.p. 186--188 °C, [@bib25]). IR ν~max~ (KBr): 3390, 2938, 1639, 1461, 1438, 1346, 1324, 1280, 1239, 1209, 1131, 1068, 990, 941, 910, 866, 848, 683, 550 cm^−1^. ^1^H NMR (δ, D~2~O, 300 MHz): 5.35 (d, 1H, *J* = 3.6 Hz, -CHOH), 4.16 (d, 1H, *J* = 8.6 Hz, -CHOH), 3.99 (t, 1H, *J* = 6.6 Hz, -CHOH), 3.84 (m, 2H, 2x-CHOH), 3.76 (m, 4H, 2x-CH~2~OH), 3.69 (d, 1H, *J* = 9.4 Hz, -CHOH), 3.62 (s, 2H, -CH~2~OH), 3.50 (m, 1H, -CHOH), 3.47 (t, 1H, *J* = 9.2 Hz, -CHOH). ^13^C NMR (δ, D~2~O, 75.5 MHz): 104.7, 93.1, 82.3, 77.5, 75.0, 73.6, 73.4, 72.0, 70.2, 63.3, 62.4, 61.1. Mass Spectral data, EIMS *m/z* (%): 324 (M^+^-H~2~O, 4), 310 (7), 181 (5), 166 (4), 148 (6), 126 (8), 114 (12), 108 (5), 102 (16), 96 (11), 84 (17), 72 (100), 60 (80), 57 (78), 43 (90).

### 2.3.1. Single crystal X-ray of AO-5 {#sec2.3.1}

Oxford CCD diffraction equipped with an Xcalibur Sapphire device (graphite monochromatic Mo-Kα radiation, λ = 0.71073 Å) was used for X-ray single crystal diffraction studies collected at 120 K using. Multiscan absorption corrections [@bib26]. [Table 1](#tbl1){ref-type="table"} exhibits the data collected and refinement parameters. SUPERFLIP was used for solving the structure [@bib27] implemented in *CRYSTALS* program suit [@bib28]. The refinement was carried out by a full-matrix least-squares method on the positional and anisotropic temperature parameters of all non-hydrogen atoms based on F^2^ using *CRYSTALS* package. Hydrogen atoms were located geometrically and refined [@bib29]. General-purpose crystallographic tool *PLATON* was used for structure investigation [@bib30]. Molecular graphics were prepared by *ORTEP-3* for Windows and *MERCURY* \[[@bib31], [@bib32]\].Table 1Refinement details and crystal data of compound **AO-5**.Table 1ParameterCrystal dataChemical formulaC~17~H~23~NO~4~S*M*~r~337.44Crystal system, space groupMonoclinic, P2~1~2~1~2Temperature (K)293*a*, *b*, *c* (Å)7.1112 (3), 18.9612 (8), 12.5124 (6)*V* (Å^3^)1687.13 (8)*Z*4Radiation typeMoKαDiffractometer*T*~min~, *T*~max~0.639, 0.908No. of measured, independent and observed \[I \> 2σ(I)\] reflections36592, 5886, 4900*R*~int~0.03(sinθ/λ)~max~ (Å^−1^)0.759*R*\[*F*^2^ \> 2σ(*F*^2^)\], *wR*(*F*^2^), *S*0.049, 0.113, 1.02No. of reflections4900No. of parameters209Δρ~max~, Δρ~min~ (e Å^−3^)0.46, −0.38

Supporting information (CIF files) can be obtained from the CCDC database (CCDC-1588571).

### 2.3.2. Computational studies {#sec2.3.2}

#### 2.3.2.1. Structure optimization {#sec2.3.2.1}

Density functional theory (DFT, ground state, in-vacuo) was undertaken for molecular structure optimization for compound **AO-5** applying hybrid functional B3LYP (Becke\'s three-parameter hybrid functional) with 6-311G+(2d,p) basis set, utilizing the Gaussian 03 package (Tables [2](#tbl2){ref-type="table"} and [3](#tbl3){ref-type="table"}, [Fig. 2](#fig2){ref-type="fig"}) [@bib33].Table 2Selected intramolecular experimental (X-ray) and computational optimized geometrical parameters (bond lengths, Å) of compound **AO-5**.Table 2Geometric parametersExperimental X-ray dataDFTO2---C31.3741.371C3---C41.3831.393C3---C81.3621.391C4---C51.3911.387C5---C61.3931.400C6---C71.3831.395C6---C91.5121.512C7---C81.3951.392C9---C101.5291.547C10---N111.51.463C10---C151.5151.526N11---C121.4961.458C12---C131.5051.523C13---C141.5081.513C14---C151.3911.397C14---C201.3941.402C15---C161.4031.401C16---C171.3791.380C17---O181.3661.366C17---C191.4021.402C19---C201.3781.384C19---O211.3741.374O21---C221.4251.421RMSE\-\--0.015Maximum difference\-\--0.038Table 3Selected intramolecular experimental (X-ray) and computational optimized geometrical parameters (bond angles, °) of compound **AO-5**.Table 3Geometric parametersExperimental X-ray dataDFTO2---C3---C4121.2117.53O2---C3---C8118.26122.78C4---C3---C8120.52119.69C3---C4---C5119.4119.67C4---C5---C6121.08121.78C5---C6---C7118.01117.51C5---C6---C9120.76120.93C7---C6---C9121.23121.56C6---C7---C8121.1121.47C7---C8---C3119.9119.89C6---C9---C10113.56113.49C9---C10---N11108.45108.50C9---C10---C15115.13112.93N11---C10---C15110.31110.59C10---N11---C12112.49113.53N11---C12---C13109.93108.05C12---C13---C14112.65110.78C13---C14---C15121.91121.20C13---C14---C20118.42119.29C15---C14---C20119.61119.50C10---C15---C14121.17121.32C10---C15---C16119.82119.77C14---C15---C16118.78118.85C15---C16---C17121.64121.52C16---C17---O18124119.91C16---C17---C19118.96119.57O18---C17---C19117.02120.52C17---C19---C20119.76119.43C17---C19---O21115.77114.40C20---C19---O21124.46126.17C14---C20---C19121.18121.12C19---O21---C22116.17118.19RMSE\-\--1.66Maximum difference\-\--4.52Fig. 2A projection of the optimized structure of compound **AO-5** by DFT/B3LYP method with 6-311G+(2d,p) basis set.Fig. 2

#### 2.3.2.2. Vibrational studies {#sec2.3.2.2}

Computed vibrational studies of compound **AO-5** were undertaken by Gaussian 03 software using the optimized geometry \[DFT/B3LYP/6-31G(d) basis set\]. To correct the theoretical errors, the scaled factor of 0.9594 was considered for all the IR frequencies. Avogadro 1.1.1 software was used to simulate the spectra of **AO-5** [@bib34] ([Table 4](#tbl4){ref-type="table"}).Table 4Calculated vibrational spectra (IR) of compound **AO-5**.Table 4Scaled freq. (cm^−1^)IntensityScaled freq. (cm^−1^)IntensityScaled freq. (cm^−1^)Intensity790.7288213.1414551.59851.638955.20147118.841260.888985.3614720.771360.049172.8914730.761540.2792312.9014810.791910.8094210.0714843.102130.359701.38150622.072511.779910.2815319.292890.67100521.64153711.763022.5510081.53159252.333070.1310302.5116121.913393.9210448.47163068.063602.91106640.81164694.2436573.9410787.69178718.603747.07112741.7217945.053862.3411463.4818174.1439958.57117322.53182429.114042.7911890.76269436.994155.01119128.61274152.634290.4712057.87275716.504470.731212100.00277341.324661.18121466.70278318.854973.9912242.19278939.215206.27123225.91279435.815355.41123812.12281214.215662.3212431.96283828.176005.50125454.67284221.176128.54126668.27289826.446440.4812932.6229078.816501.2613175.39292523.876581.21132462.81292717.877192.70133764.8729280.457590.8913507.7029334.747932.86135217.6430050.3682654.3113688.15358060.4885223.52138938.11358126.368679.21140393.45

#### 2.3.2.3. NMR studies {#sec2.3.2.3}

Computed NMR studies of compound **AO-5** was carried out by Gaussian 03 program, DFT/B3LYP/6-311G+(2d,p)/GIAO (Gauge-Independent Atomic Orbital) for the optimized structure at the same level of theory. The predicted ^1^H and ^13^C NMR chemical shifts were derived from the equation; δ = (intercept - σ)/‒slope, where δ is the scaled chemical shift values (δ relative to TMS), σ is the computed isotropic shielding constants and the slope (for ^1^H NMR = 1.0593, ^13^C NMR = 1.0228) and intercept (for ^1^H NMR = 32.0706, ^13^C NMR = 181.3782) from the linear regression analysis [@bib35], <http://cheshirenmr.info/ScalingFactors.htm>) ([Table 5](#tbl5){ref-type="table"}).Table 5Theoretical ^1^H and ^13^C NMR chemical shifts (δ, ppm) of compound **AO-5**.Table 5AtomCalculated (δ, ppm) DFT/B3LYP method with 6-311G+(2d,p) basis setNH1.45H~2~C-42.84, 3.43 (average = 3.14)Benzyl CH~2~2.76, 3.83 (average = 3.30)H~2~C-33.26, 3.50 (average = 3.38)H-14.21OCH~3~4.12, 4.14, 4.48 (average = 4.25)OH3.64OH4.71H-56.24H-3\'/5′6.19, 6.64 (average = 6.42)H-86.68H-2\'/6′6.93, 7.04 (average = 6.99)H~2~C-435.5Benzyl CH~2~46.1H~2~C-348.8OCH~3~55.0HC-159.1C-5102.4C-8103.6C-3′104.6C-5′106.9C-4a116.8C-2′120.6C-1′122.6C-8a123.0C-6′124.6C-7135.9C-6137.0C-4′146.5

### 2.3.3. Biological studies {#sec2.3.3}

#### 2.3.3.1. Animals {#sec2.3.3.1}

Male LACA 2--3 months old mice (25--30 g), (Central Animal House, Punjab University, India) were used. Prior to the experiment all the animals were acclimatized to the laboratory environment. A standard protocol approved by the Institutional Animal Ethics Committee followed in accordance with the Indian National Science Academy Guidelines to keep and care the animals in the facility. All the animal studies were carried out between 9.00 and 17.00 h.

#### 2.3.3.2. Drugs and treatment schedule {#sec2.3.3.2}

D-galactose and optimized extract of *Aporosa octandra* (**AOE-4**) were used for the study. D-galactose made with deionized water for subcutaneous (s.c.) administration. **AOE-4** solution administered to the mice orally in a dose of 1 ml/100g body weight which was prepared by suspending AOE-4 in 0.25% w/v sodium carboxymethyl cellulose. Animals were randomized into eight groups, consists of 5 animals in each.

I. Naïve group administered 0.5% Sodium carboxymethyl cellulose.

II\. D-galactose treated group administered 100 mg/kg of D-galactose subcutaneously.

III, IV & V. **AOE-4** (100, 200 & 300 mg/kg p.o.) solution was administered to the per se groups.

VI, VII & VIII. **AOE-4** (100, 200 & 300 mg/kg, p.o.) was administered to D-galactose treated mice.

The study was carried out for a period of 42 days (6 weeks).

2.4. Behavioral assessments {#sec2.4}
---------------------------

### 2.4.1. Assessment of cognitive performance {#sec2.4.1}

#### 2.4.1.1. Morris water maze experiment {#sec2.4.1.1}

The Morris water maze technique was used to evaluate the acquisition and retention of memory \[[@bib13], [@bib14]\]. Morris water maze is a large circular pool of 45 cm in height and 150 cm in diameter, filled with of water at 28 ± 1 °C to a depth of 30 cm. The pool was used to carry out the experiments by following the procedure described in the report [@bib14].

#### 2.4.1.2. Maze acquisition phase (training) {#sec2.4.1.2}

All the Animals trained with 4 trials in each session on day 20. Every trial was having different starting position. The time taken by the mouse to reach the visual platform was noted as the initial acquisition latency (IAL). After the end of each trial, mice were directed to their respective home cages.

#### 2.4.1.3. Maze retention phase (testing for retention of the learned task) {#sec2.4.1.3}

On day 21 (following 24 hours) and 21 days (day 42) after IAL, the mice was released randomly at one of the edges facing the wall of the pool to assess for memory retention. Time taken by mice to find the hidden platform on day 21 and 42 following D-galactose administration were recorded, labeled as first retention latency (1^st^ RL) and second retention latency (2^nd^ RL) respectively.

### 2.4.2. Assessment of gross behavioral activity {#sec2.4.2}

Gross behavioral activity was observed at weekly interval. Each animal was placed in a square (30 cm) closed arena equipped with infrared light-sensitive photocells using digital actophotometer. The animal was observed for a period of 5 min and expressed as counts/5 min. The apparatus was placed in a darkened, light and sound attenuated and ventilated test room [@bib13].

### 2.4.3. Biochemical assessment {#sec2.4.3}

Biochemical tests were conducted after performing the Morris water Maze task paradigm. The animals were sacrificed and brains were removed and rinsed with ice-cold isotonic saline. Brains were then homogenized with ice-cold 0.1 mmol/L phosphate buffer (pH 7.4). The homogenates (10 % w/v) were then centrifuged at 10,000 rpm for 15 min and the supernatant so formed was used for the biochemical estimations.

### 2.4.4. Measurement of lipid peroxidation {#sec2.4.4}

The quantitative measurement of lipid peroxidation in brain tissue was performed according to the method described by Wills, 1966 [@bib36]. The amount of malondialdehyde (MDA), a marker of lipid peroxidation was assayed in the form of thiobarbituric acid reacting substances (TBARS). Briefly, 0.5 ml of supernatant containing 0.5 ml TrisHCl was incubated at 37 °C for 2 h. After incubation, 1 ml of 10 % trichloroacetic acid (TCA) was added and centrifuged at 10,000 rpm for 10 min and from the resulting supernatant 1 ml of it was collected which was further followed by the addition of 1ml of 0.67% thiobarbituric acid (TBA). Lastly, the tubes were kept in boiling water for 10 min. After cooling 1 ml double distilled water was added and absorbance was measured at 532 nm using a spectrophotometer (Shimadzu, Japan). TBARS were quantified using an extinction coefficient of 1.56 × 10^5^ M^−1^cm^−1^ and expressed as nmol of MDA per mg protein [@bib13].

### 2.4.5. Superoxide dismutase activity {#sec2.4.5}

Superoxide dismutase (SOD) activity was determined by following the reported method [@bib37]. A mixture of 0.1 mM of EDTA, 50 mM of sodium carbonate and 96 mM of nitro blue tetrazolium (NBT) were used for the assay. 2 ml of the above mixture, 0.05 ml of hydroxylamine and 0.05 ml of the supernatant were mixed and then the auto-oxidation of hydroxylamine was measured for 2 min at 30 sec interval by at 560 nm using Perkin Elmer Lambda 20 spectrophotometer [@bib13].

### 2.4.6. Estimation of acetylcholinesterase (AChE) activity {#sec2.4.6}

AChE is a marker of loss of cholinergic neurons in the brain region. The standard Ellman method was used to assess the AChE [@bib38]. The Ellman reagent (0.1 ml) was missed with 0.05 ml of supernatant, 3 ml of sodium phosphate buffer (pH 8), and 0.1 ml of acetylthiocholine iodide and the change in absorbance was measured for 2 min at 30 s interval at 412 nm using Perkin Elmer Lambda 20 spectrophotometer. Results were expressed as micromoles of acetylthiocholine iodide hydrolyzed per min per mg of protein [@bib13].

### 2.4.7. Protein estimation {#sec2.4.7}

The protein content was estimated by the Biuret method [@bib39] using bovine serum albumin as a standard.

### 2.4.8. Statistical analysis {#sec2.4.8}

Values are expressed as mean ± SEM (standard error mean). The behavioral assessment data were examined by a repeated measures two-way analysis of variance (ANOVA) with treated groups as between and sessions as the within-subjects factors. The biochemical estimations were analyzed by one-way ANOVA and Post hoc comparisons between groups were made using Tukey\'s test. P \< 0.05 was considered significant.

3. Results & discussion {#sec3}
=======================

3.1. Fractionation of AOE-1 and AOE-4 extracts {#sec3.1}
----------------------------------------------

The column was packed with silica gel of 120 mesh size and eluted with a gradient of hexanes/CH~2~Cl~2~/MeOH. A total of 97 fractions (300 ml each) from **AOE-1** were collected and combined on the basis of their TLC behavior to make seven major fractions (F1--F7). Similarly, 95 fractions (300 ml each) were collected from **AOE-4** and pooled based on their TLC behavior to make nine major fractions (F1a--F9a). Isolation of the compounds was accomplished upon repeated column chromatography of fractions collected from **AOE-1** and **AOE-4** followed by crystallization. Three compounds, pentyl docosanoate (**AO-1**, 12 mg), tetradecanoic acid (**AO-2**, 15 mg) and stigmast-5-en-3β-ol (**AO-3**, 40 mg) were isolated from **AOE-1**. Similarly, stigmast-5-en-3-O-β-D-galactopyranoside (**AO-4**, 20 mg), **(*R*)-1-(4-**hydroxybenzyl)-6-methoxy-1,2,3,4-tetrahydroisoquinolin-7-ol ((*R*)-Coclaurine **AO-5**, 160 mg) and β-D-fructofuranosyl-α-D-glucopyranoside (**AO-6**, 140 mg) were isolated from **AOE-4**. All these compounds are reported here for the first time from *Aporosa octandra* (Figs. [3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}). All the isolated compounds were fully characterized by various spectroscopic techniques and confirmed with the reported data. Compound **AO-5** is an alkaloid also isolated earlier from the leaves of *Nelumbo nucifera* [@bib40], the root and bark of *Xylopia parviflora* [@bib41] and from the stems of *Aristolochia ridicula* [@bib42]. Even the structure of (*R*)-Coclaurine was reported earlier, herein for the first time we investigated the structure by X-ray and DFT studies.Fig. 3Schematic representation of the extraction/fractionation process of *A.octandra*.Fig. 3Fig. 4Chemical structure of compounds **AO-1-AO-6** isolated from the bark of *Aporosa octandra*.Fig. 4

3.2. Single crystal X-ray studies {#sec3.2}
---------------------------------

The crystal structure of compound **AO-5** was confirmed by single crystal X-ray diffraction studies. Compound **AO-5** crystallizes in the orthorhombic space group *P*2~1~2~1~2 with tetrahydroisoquinoline scaffold. It consists of a p-hydroxybenzyl moiety nearly perpendicular to the tetrahydroisoquinolinyl heterocycle with a dihedral angle of 81.34° in addition to a hydrogen sulfide and one water molecule in the crystalline form ([Fig. 5](#fig5){ref-type="fig"}). The two atoms N11 and C12 are displaced from the plane of the heterocyclic ring N11-C10 by 0.322 Å and 0.301 Å, respectively. The overall geometrical parameters are of good agreement with previously reported structures having similar scaffolds \[[@bib43], [@bib44], [@bib45], [@bib46]\]. The principal interest in the structure lies in the inter and intra-molecular hydrogen bonds, particularly the hydrogen bonds that link the free water and hydrogen sulfide molecules with the main heterocycle ([Table 6](#tbl6){ref-type="table"}). These hydrogen bonds also stabilize the crystal structure and result in forming supramolecular layers ([Fig. 6](#fig6){ref-type="fig"}).Fig. 5ORTEP view of compound **AO-5**, showing the atom-labeling scheme. Displacement ellipsoids are drawn at the 30% probability level.Fig. 5Table 6Hydrogen-bond geometry of compound **AO-5** (Å).Table 6*D*---H···*AD*---HH···*AD*···*AD*---H···*A*S1---H12···N11^i^0.802.623.201(4)130O23---H231···O2^i^0.841.952.769(2)164O23---H232···O18^ii^0.832.333.059(2)147O23---H232···O21^ii^0.832.182.836(2)136O18---H181···S1^ii^0.852.323.158(3)171O2---H21···O23^iii^0.791.852.643(3)176C12---H121···S1^iv^0.962.843.734(2)154[^1]Fig. 6Crystal packing of **AO-5** showing the hydrogen-bond interactions as dashed lines.Fig. 6

3.3. Optimized structure {#sec3.3}
------------------------

Comparing the geometrical parameters of the DFT optimized structure with the experimental structure (X-ray) of **AO-5** shows a good fit (Tables [2](#tbl2){ref-type="table"} and [3](#tbl3){ref-type="table"}). The highest difference between the experimental and calculated bond lengths is 0.038 Å, with root mean square error (RMSE) 0.015 Å. For bond angles, the biggest difference between the experimental and calculated values is 4.52° with RMSE 1.66°. The overall comparison was performed by superimposing the molecular skeletons obtained from X-ray diffraction with the corresponding one of the DFT method ([Fig. 7](#fig7){ref-type="fig"}). It is obvious that most functions are aligned well with each other with a little deviation. This difference is noticed for the methoxy group attached to the tetrahydroisoquinoline as the torsion angle of C20-C19-O21-C22 for the single X-ray data = −7.09°; however, for DFT it is −0.15°. This observation can be attributed to the effect of lattice form affecting the X-ray structural behavior. Whereas, in the theoretical studies this effect is completely neglected.Fig. 7Overlay diagram of compound **AO-5**, red (X-ray structure), green (DFT).Fig. 7

3.4. Computed vibrational studies {#sec3.4}
---------------------------------

Computed IR spectrum of compound AO-5 ([Table 4](#tbl4){ref-type="table"}, [Fig. 8](#fig8){ref-type="fig"}) utilizing DFT/B3LY, 6-31G(d) basis set reveals the presence of hydroxyl and imino stretching vibration bands at ν = 3581, 3580 cm^−1^ in addition to 2925, 2898, 2838, 1646, 1630, 1592, 1506 due to the other vibrational functions/groups. The computational spectrum is correlated with the experimental one considering that the difference(s) is due to the computational study is for the gaseous state while the experimental for solid state (KBr pellet).Fig. 8Simulated IR spectrum of compound **AO-5** computed by DFT/B3LYP method with 6-31G(d) basis set.Fig. 8

3.5. Computed NMR studies {#sec3.5}
-------------------------

Theoretical ^1^H NMR \[DFT/B3LYP/6-311G+(2d,p)/GIAO\] of compound **AO-5** exhibits the isoquinolinyl methylene H~2~C-4 and H~2~C-3 in addition to the benzylic H~2~C at δ~H~ = 3.14, 3.38, 3.30, respectively (comparable to the experimental data at δ~H~ = 3.01, 3.46, 3.33, respectively). The isoquinolyl methine HC-1 and methoxy protons are shown at δ~H~ = 4.21, 4.25, respectively (experimentally at δ~H~ = 4.58, 3.84, respectively). Theoretical ^13^C NMR reveals the isoquinolinyl C-4, C-3, C-1 and benzylic carbon at δ~C~ = 35.5, 48.8, 59.1, 46.1, respectively (experimentally at δ~C~ = 26.0, 41.0, 57.9, 40.5, respectively). The methoxy carbon is shown at δ~C~ = 55.0 (experimentally at δ~C~ = 56.5). The theoretical NMR data are derived from the gaseous state (in vacuo) but the experimental was undertaken in a solvent (MeOH-*d*~4~). This fact can justify the difference between the experimental and computational NMR data ([Table 5](#tbl5){ref-type="table"}).

3.6. Biological studies {#sec3.6}
-----------------------

### 3.6.1. Effect of *Aporosa octandra* extract (**AOE-4**) on memory performance in Morris water maze experiment in D-galactose induced mice {#sec3.6.1}

**AOE-4** (100, 200 & 300 mg/kg) per se group of animals and naive easily learned to swim straight to the platform in the Morris water maze via special navigation task on day 20. Initially, there was a sign of an increase in escape latency with the D-galactose-treated mice, which slowly declined on day 20 with continuous training through the acquisition of the navigation task. On day 20 there was significant difference in the initial acquisition latencies (IAL) value of D-galactose treated and the naive group of animals, which implies that chronic use of D-galactose impaired acquisition of spatial navigation task (P \< 0.05). However, co-administration of D-galactose with **AOE-4** (100, 200 & 300 mg/kg) shows a significant decrease in the IAL the pre-trained animals in compared to D-galactose-treated on day 20 of the experiment ([Table 7](#tbl7){ref-type="table"}).Table 7Effect of *Aporosa octandra***AOE-4** (AOE-4; 100, 200 and 300 mg/kg, p.o.) in D-galactose induced mice on memory performance in Morris water maze experiment.Table 7Treatment (mg/kg)Day 20\
(ITL)Day 21\
(1st RTL)Day 42\
(2nd RTL)Naïve77.5 ± 2.415 ± 2.710.0 ± 2.5D-Gal (100)88 ± 2.387.8 ± 2.6^a^84.3 ± 2.3^a^AOE-4 (100)84.5 ± 2.620.5 ± 2.618.5 ± 2.4AOE-4 (200)80 ± 2.520 ± 316 ± 2.1AOE-4 (300)79.8 ± 2.216.8 ± 2.712.5 ± 2.7AOE-4 (100) + D-Gal (100)83.5 ± 2.875.4 ± 2.572.8 ± 2.5AOE-4 (200) + D-Gal (100)78.4 ± 369.8 ± 2.5^b^55.5 ± 3.2^b^AOE-4 (300) + D-Gal (100)75 ± 2.445.5 ± 2.5^b,c^38 ± 2.4^b,c^[^2]

The mean retention latencies (1^st^ and 2^nd^ RL) and mean IAL data of the naive group and the D-galactose treated group mice on days 21 and 42 suggest D-galactose causes significant cognitive impairment in the mice \[[@bib13], [@bib14]\]. However, there was a significant decrease in 1^st^ RL and 2^nd^ RL on days 21 and 42, respectively in the group of mice which were administered **AOE-4** (100, 200 & 300 mg/kg) chronically to D-galactose treated mice in compared to only D-galactose treated mice ([Table 7](#tbl7){ref-type="table"}).

### 3.6.2. Effect of *Aporosa octandra* extract (**AOE-4**) on brain lipid peroxidation in D-galactose treated mice {#sec3.6.2}

Chronic administration of D-galactose significantly causes increase in Malondialdehyde (MDA) formation as compared to naïve mice (*P* \< 0.05) \[[@bib47], [@bib48], [@bib49]\]. Chronic **AOE-4** (100, 200 and 300 mg/kg, p.o.) administration significantly attenuated the oxidative damage by reducing the MDA and nitrite levels as compared to control group (D-galactose treated group) levels as well standard galantamine. Furthermore, **AOE-4** (100 mg/kg, p.o.) per se treatment did not produce any significant effect on MDA and nitrite levels as compared to naive mice ([Fig. 9](#fig9){ref-type="fig"}).Fig. 9Effect of *Aporosa octandra* (**AOE-4**; 100, 200 and 300 mg/kg, p.o.) on lipid peroxidation in D-galactose treated mice. Values are mean ± S.E.M. ^a^P \< 0.05 as compared to the naïve group; ^b^P \< 0.05 as compared to D-galactose treated group; ^c^P \< 0.05 as compared to Aporosa (200) + D-galactose group; (Repeated measures one-way ANOVA followed by Tukey\'s test for multiple comparisons).Fig. 9

3.7. Effect of *Aporosa octandra* extract (AOE-4) on reduced glutathione, superoxide dismutase in D-galactose-treated mice {#sec3.7}
--------------------------------------------------------------------------------------------------------------------------

Chronic administration of D-galactose leads to significant decrease in superoxide dismutase (SOD) level in the brain as compared to naive mice (P \< 0.05). However, chronic administration of **AOE-4** (200 and 300 mg/kg, p.o.) restores the SOD level in the D-galactose treated mice as compared to standard galantamine. Furthermore, **AOE-4** (100 mg/kg, p.o.) per se treatment did not effect on SOD levels as compared to naive mice ([Fig. 10](#fig10){ref-type="fig"}).Fig. 10Effect of *Aporosa octandra* (**AOE-4**; 100, 200 and 300 mg/kg, p.o.) on superoxide dismutase in D-galactose treated mice. Values are mean ± S.E.M. ^a^P \< 0.05 as compared to the naïve group; ^b^P \< 0.05 as compared to D-galactose treated group; ^c^P \< 0.05 as compared Aporosa (200) + D-galactose group; (Repeated measures one-way ANOVA followed by Tukey\'s test for multiple comparisons).Fig. 10

3.8. Effect of *Aporosa octandra* extract (**AOE-4**) on acetylcholinesterase activity in D-galactose treated mice {#sec3.8}
------------------------------------------------------------------------------------------------------------------

Chronic administration of D-galactose leads to significant increase in acetylcholinesterase activity as compared to naive mice (P \< 0.05) [@bib50]. However, chronic administration of **AOE-4** (100, 200 and 300 mg/kg, p.o.) decreases the elevated acetylcholinesterase activity in the D-galactose treated mice and the results were compared with the standard galantamine ([Fig. 11](#fig11){ref-type="fig"}).Fig. 11Effect of *Aporosa octandra* (**AOE-4**; 100, 200 and 300 mg/kg, p.o.) on acetylcholinesterase activity in D-galactose treated mice. Values are mean ± S.E.M. ^a^P \< 0.05 as compared to the naïve group; ^b^P \< 0.05 as compared to D-galactose treated group; (Repeated measures one-way ANOVA followed by Tukey\'s test for multiple comparisons).Fig. 11

Several reports suggest D-galactose leads to learning & memory impairment and oxidative damage in rodents \[[@bib51], [@bib52]\]. Our experiments demonstrated that chronic administration of **AOE-4** extract can improve learning and memory impairment and reduced oxidative damage decreasing the elevated MDA level, restoring the reduced activity of SOD and reversed the AChE activity in D-galactose induced.

In conclusion, we identified an unexplored medicinal plant, which has the ability to control oxidative damages. To better understand the mechanism of **AOE-4** on aging and oxidative stress, further cellular level studies are required. Compound **AO-5** was characterized and is the major compound isolated from **AOE-4**. **AO-5** could be therefore used for further investigation and development of potential anti-aging agents.
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[^1]: Symmetry codes: (i) 1/2+x,-1/2-y,-z; (ii) -x,-1-y,z; (iii) -1+x,y,1+z; (iv) -1+x,y,z.

[^2]: The initial acquisition latencies (IAL) on day 20 and retention latencies on days 21 (1^st^ RL) and 42 (2^nd^ RL) following D-gal concurrent treatment were observed. Values are mean ± S.E.M. ^a^P \< 0.05 as compared to the naive group; ^b^P \< 0.05 as compared to D-gal treated group; ^c^P \< 0.05 as compared to Aporosa (200) + D-gal group (Repeated measures one-way ANOVA followed by Tukey\'s test for multiple comparisons).
